Investigation of the Dynamic Gait Index in children: a pilot study.
Anat Lubetzky-Vilnai, Tracy L Jirikowic, Sarah Westcott McCoy
https://pubmed.ncbi.nlm.nih.gov/21829122/Actively Recruiting
Led by Istanbul University - Cerrahpasa · Updated on 2026-06-02
52
Participants Needed
1
Research Sites
4 weeks
Total Duration
Juvenile idiopathic arthritis JIA is a common chronic rheumatic disease in children that causes pain, joint swelling, and loss of function, which can reduce quality of life and lead to muscle weakness, limited motion, and walking difficulties. Researchers are evaluating the Dynamic Gait Index DGI as a new tool to assess walking ability in children with JIA, since current methods lack a functional walking test for this group. The study aims to determine whether the DGI is a reliable and valid measure for evaluating walking challenges in these children. The study includes two groups children diagnosed with JIA and age-matched healthy volunteers. The DGI test measures walking on level ground, changing speed, head turns, pivot turns, jumping over obstacles, walking around obstacles, and climbing stairs. Each activity is scored to assess walking ability. Additional physical tests include the Timed Up and Go Test, walking speed measurement, Wong-Baker FACES Pain Scale for pain assessment, Pediatric Balance Scale, and Childhood Health Assessment Questionnaire. These tests will be conducted at the start and again two weeks later. Participants will undergo physical examinations involving several walking and balance tests. Researchers will measure outcomes such as the DGI score, walking speed, timed up and go performance, pain levels, and balance ability. These measurements will help evaluate the walking function and risks related to falls in children with JIA compared to healthy peers. The study will monitor participants over a two-week period after baseline testing to assess the consistency and reliability of the DGI for this purpose.
CONDITIONS
Dynamic Gait Index as a Functional Gait Assessment Measure in Children With JIA
G
Gökçe Leblebici, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Istanbul University - Cerrahpasa
Lead Sponsor
Medipol University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Baseline and 2 weeks after baseline
Participants undergo physical examinations including Timed Up and Go Test, Walking speed, Wong-Baker FACES Pain Scale, Pediatric Balance Scale, Childhood Health Assessment Questionnaire, and the Dynamic Gait Index to assess walking ability and risk of falling.
2 visits (in-person)
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Anat Lubetzky-Vilnai, Tracy L Jirikowic, Sarah Westcott McCoy
https://pubmed.ncbi.nlm.nih.gov/21829122/A Shumway-Cook, M Baldwin, N L Polissar...
https://pubmed.ncbi.nlm.nih.gov/9256869/Carlos Balsalobre-Fernández, Carlos M Tejero-González, Juan del Campo-Vecino...
https://pubmed.ncbi.nlm.nih.gov/23689339/H Ozdogan, N Ruperto, O Kasapçopur...
https://pubmed.ncbi.nlm.nih.gov/11510322/Mary Rose Franjoine, Joan S Gunther, Mary Jean Taylor
https://pubmed.ncbi.nlm.nih.gov/17057441/Alberto Martini, Daniel J Lovell, Salvatore Albani...
https://pubmed.ncbi.nlm.nih.gov/35087087/Johanna Jonsdottir, Davide Cattaneo
https://pubmed.ncbi.nlm.nih.gov/17964880/Angelo Ravelli, Alberto Martini
https://pubmed.ncbi.nlm.nih.gov/17336654/Courtney D Hall, Susan J Herdman
https://pubmed.ncbi.nlm.nih.gov/16796772/Talia Herman, Noit Inbar-Borovsky, Marina Brozgol...
https://pubmed.ncbi.nlm.nih.gov/18845439/Istanbul University - Cerrahpasa
Lead Sponsor
Medipol University
Collaborating Sponsor